Clarivate CLVT Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| Academia & Government Group | $1.27B-4.6% | $1.33B+0.2% | $1.32B+3.4% | $1.28B— | |
| Intellectual Property Group | $799.4M-1.5% | $811.4M-5.9% | $862.7M-6.9% | $927.1M-4.8% | |
| Life Sciences & Healthcare | $389.8M-6.9% | $418.9M-5.4% | $442.8M-2.2% | $452.6M— | |
| Royalty And Other Product Expense by Business | |||||
| Academia & Government Group | $215.4M-13.3% | $248.5M+0.3% | $247.7M-2.1% | $253.1M— | |
| Intellectual Property Group | $75.5M-0.8% | $76.1M-16.6% | $91.3M-19.6% | $113.5M— | |
| Life Sciences & Healthcare | $37.3M-0.8% | $37.6M-13.6% | $43.5M+2.4% | $42.5M— | |
| Other Cost and Expense, Operating by Business | |||||
| Academia & Government Group | $47.3M+7.5% | $44M-3.7% | $45.7M-1.9% | $46.6M— | |
| Intellectual Property Group | $23.6M-9.6% | $26.1M+0.4% | $26M-0.4% | $26.1M— | |
| Life Sciences & Healthcare | $10.4M-15.4% | $12.3M-12.8% | $14.1M+2.9% | $13.7M— | |
| Adjusted EBITDA by Business | |||||
| Academia & Government Group | $548M-2.8% | $563.8M+0.9% | $558.5M+15.0% | $485.5M— | |
| Intellectual Property Group | $334.1M-6.8% | $358.5M-10.5% | $400.4M-9.6% | $443M+17.8% | |
| Life Sciences & Healthcare | $119.7M-13.3% | $138.1M-12.8% | $158.3M-14.1% | $184.2M— | |
| Technology Expenses by Business | |||||
| Academia & Government Group | $78.8M-2.1% | $80.5M+6.5% | $75.6M+8.6% | $69.6M— | |
| Intellectual Property Group | $50.9M+9.9% | $46.3M+3.8% | $44.6M+3.7% | $43M— | |
| Life Sciences & Healthcare | $28.6M+5.5% | $27.1M+10.6% | $24.5M+13.4% | $21.6M— | |
| Outside Service Expense by Business | |||||
| Academia & Government Group | $33.8M-15.3% | $39.9M-7.2% | $43M-6.9% | $46.2M— | |
| Intellectual Property Group | $20.9M-0.9% | $21.1M-7.0% | $22.7M-20.9% | $28.7M— | |
| Life Sciences & Healthcare | $10.6M-18.5% | $13M-9.7% | $14.4M-30.1% | $20.6M— | |
| People-Related Expenses by Business | |||||
| Academia & Government Group | $342.7M-2.0% | $349.7M-0.9% | $352.8M-6.9% | $379.1M— | |
| Intellectual Property Group | $294.4M+3.9% | $283.3M+2.0% | $277.7M+1.8% | $272.8M— | |
| Life Sciences & Healthcare | $183.2M-4.0% | $190.8M+1.5% | $188M+10.6% | $170M— | |
| Restructuring costs by Business | |||||
| Academia & Government Group | $21.2M+203% | $7M-50.4% | $14.1M-60.9% | $36.1M— | |
| Intellectual Property Group | $15.7M+171% | $5.8M-37.0% | $9.2M-54.0% | $20M-72.8% | |
| Life Sciences & Healthcare | $13.8M+103% | $6.8M-37.6% | $10.9M— | —— | |
| Revenue by Product | |||||
| Re-occurring Revenues | $434.2M+1.0% | $429.8M-3.3% | $444.6M+0.6% | $441.9M— | |
| Subscription revenues | $1.61B-1.3% | $1.63B+0.5% | $1.62B0.0% | $1.62B— | |
| Transactional and other revenues | $415.5M-16.9% | $500.1M-11.7% | $566.1M— | —— | |
| Revenue by Geography | |||||
| Asia Pacific | $497.4M-2.0% | $507.5M-1.6% | $515.8M+3.3% | $499.2M+25.9% | |
| EMEA | $654.8M-1.9% | $667.8M-5.6% | $707.5M+1.3% | $698.3M+25.6% | |
| North America | $1.3B-5.7% | $1.38B-1.7% | $1.41B-3.9% | $1.46B+58.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Clarivate break its business down?
- Clarivate (CLVT) reports revenue by business across 3 parts — Academia & Government Group, Intellectual Property Group and Life Sciences & Healthcare. Each is extracted from the segment footnotes and tracked over time.
- Where does Clarivate's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Clarivate's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
